Biomedical Engineering Reference
In-Depth Information
TAble 9.2
Chitosan-Based Biological Factor or Cell Delivery Systems for Tissue Engineering
Growth Factors
Actions
Substrate Material
Applications
BMP-2
Bone morphogenesis
Chitosan
Bone regeneration
Chitosan-poly(glutamic acid)
Osseointegration
PDGF-BB
Mitogenic
Chitosan
Bone regeneration
Bone formation and
remodeling
Chitosan-chondroitin sulfate
Periodontics
Chitosan-poly(l-lactide)
Orthopedics
Plastic surgery
TGF-β
Multifunctional
Chitosan
Bone and cartilage
regeneration
Chitosan-collagen
Chitosan-tricalcium phosphate
Chitosan-collagen-chondroitin sulfate
FGF-2
Mitogenic
Chitosan-lactose hydrogel
Angiogenesis
Angiogenic
Photocross-linkable azide-chitosan-
lactose hydrogel
Wound healing
Regulates cell
differentiation
EGF
Angiogenic
EC proliferation
Chitosan
Wound healing
VEGF
Angiogenic
EC proliferation
Chitosan-dextran sulfate nanoparticles
Angiogenesis
Source: From Jiang, T. et al. 2008. Curr Top Med Chem 8: 354-364. With permission.
difficult to control. That all these behaviors depended on the electrostatic interactions
between growth factors and scaffolds is the main factor. One can modulate the release
behaviors by adjusting the interactions between growth factors and chitosan-based scaf-
folds. The isoelectric points of bFGF, platelet-derived growth factor-BB (PDGF-BB), and
transforming growth factor-β (TGF-β) are 9.6, 9.8, and 8.59, respectively. Under physio-
logical conditions, ionic repulsion between chitosan and these growth factors exists,
which results in low absorption and burst release. The rapid release phenomena are more
obvious when some cationic polymer or protein (isoelectric point higher than 7.4) is
incorporated into the chitosan scaffold. For example, the release rate of TGF-β loaded in
chitosan-collagen scaffolds is higher than that in pure chitosan scaffolds [75]. It is favor-
able to reduce the release rate when some polyanion polymers are incorporated into
chitosan due to the electrostatic attraction interaction between polyanion polymers and
growth factors or chitosan. For example, a more steady release of PDGF-BB may be obtained
by using the chitosan-chondroitin-4-sulfate scaffold than by using chitosan alone. And
the release of PDGF-BB is efficiently sustained because the content of chondroitin-4-sulfate
in the chitosan scaffold increased [76]. In order to improve the binding efficiency and
decrease the burst release of bFGF, Mi and coworkers [77] conjugated heparin on the chi-
tosan-alginate scaffold surface. The heparinized scaffolds exhibited higher affinity than
the chitosan-alginate scaffold alone. The scaffolds are uniquein their ability to bind bFGF
depending on the amount of conjugated heparin. The more the content of heparin, the
higher the binding efficiency. Moreover, the rate of bFGF release from the scaffold decreased
in a controlled manner with decreasing burst effect. For all that, the physical adsorption
Search WWH ::




Custom Search